Overview

Bioequivalence of Two Formulations of Esomeprazole

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
Bioequivalence of Two Formulations of Esomeprazole 40mg
Phase:
Phase 4
Details
Lead Sponsor:
Yung Shin Pharm. Ind. Co., Ltd.
Collaborator:
Taichung Veterans General Hospital
Treatments:
Esomeprazole